[Studies on man for the hyaluronidase-inhibiting effect of phenylbutazone and its blocking by adrenolytics. anthistaminics and heparin-inactivating substances].
D018674:Adrenergic Antagonists; D018926:Anti-Allergic Agents; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000494:pharmacology*; D006493:Heparin; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000037:antagonists & inhibitors*; D008297:Male; D010120:Oxytocics; D010653:Phenylbutazone / Q000494:pharmacology*; D011479:Protamines / Q000494:pharmacology*
D018674:Adrenergic Antagonists; D018926:Anti-Allergic Agents; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D006634:Histamine H1 Antagonists; D010120:Oxytocics; D011479:Protamines; D006493:Heparin; D006821:Hyaluronoglucosaminidase; D010653:Phenylbutazone
ANTIHISTAMINICS/pharmacology; ERGOT ALKALOIDS/pharmacology; HYALURONIDASE/antagonists; PHENYLBUTAZONE/pharmacology; PROTAMINES/pharmacology